Department of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, NY 11794, USA.
Infect Immun. 2010 Aug;78(8):3529-39. doi: 10.1128/IAI.00269-10. Epub 2010 Jun 1.
The YopM protein of Yersinia sp. is a type III secreted effector that is required for virulence in murine models of infection. YopM has previously been shown to contain leucine-rich repeats (LRRs) and to interact with two host kinases, RSK1 and PRK2, although the consequence of these interactions is unknown. A series of YopM proteins missing different numbers of LRRs or a C-terminal domain were produced and used for in vitro binding reactions to map domains required for interaction with RSK1 and PRK2. A C-terminal domain of YopM (from LRR12 to the C terminus) was shown to be required for interaction with RSK1, while an internal portion encompassing LRR6 to LRR15 was shown to be required for interaction with PRK2. The virulence of a Yersinia pseudotuberculosis Delta yopM mutant in mice via an intravenous route of infection was significantly attenuated. At day 4 postinfection, there were significantly increased levels of gamma interferon and reduced levels of interleukin-18 (IL-18) and IL-10 in the serum of the Delta yopM-infected mice compared to that of mice infected with the wild type, suggesting that YopM action alters the balance of these key cytokines to promote virulence. The PRK2 and RSK1 interaction domains of YopM were both required for IL-10 induction in vivo, irrespective of splenic colonization levels. In an orogastric model of Y. pseudotuberculosis infection, a Delta yopM mutant was defective in dissemination from the intestine to the spleen and significantly reduced in virulence. In addition, Y. pseudotuberculosis mutants expressing YopM proteins unable to interact with either RSK1 (YopM Delta 12-C) or PRK2 (YopM Delta 6-15) were defective for virulence in this assay, indicating that both interaction domains are important for YopM to promote pathogenesis.
耶尔森氏菌的 YopM 蛋白是一种 III 型分泌效应物,是感染鼠模型中毒力所必需的。先前已经表明,YopM 含有亮氨酸丰富的重复序列 (LRR),并且与两种宿主激酶 RSK1 和 PRK2 相互作用,尽管这些相互作用的后果尚不清楚。产生了一系列缺失不同数量的 LRR 或 C 末端结构域的 YopM 蛋白,并用于体外结合反应以绘制与 RSK1 和 PRK2 相互作用所需的结构域。YopM 的 C 末端结构域(从 LRR12 到 C 末端)被证明与 RSK1 相互作用,而包含 LRR6 到 LRR15 的内部部分被证明与 PRK2 相互作用。通过静脉途径感染小鼠时,耶尔森氏菌假结核亚种 Delta yopM 突变体的毒力明显减弱。在感染后第 4 天,与野生型感染的小鼠相比,Delta yopM 感染的小鼠血清中γ干扰素水平显著升高,白细胞介素-18 (IL-18) 和白细胞介素-10 (IL-10) 水平降低,表明 YopM 作用改变了这些关键细胞因子的平衡,促进了毒力。YopM 的 PRK2 和 RSK1 相互作用结构域在体内诱导 IL-10 均需要,而与脾定植水平无关。在耶尔森氏菌假结核亚种感染的经口模型中,Delta yopM 突变体在从肠道传播到脾脏方面存在缺陷,毒力显著降低。此外,在该测定中,无法与 RSK1(YopM Delta 12-C)或 PRK2(YopM Delta 6-15)相互作用的 YopM 蛋白表达的耶尔森氏菌假结核亚种突变体的毒力也存在缺陷,表明这两个相互作用结构域对于 YopM 促进发病机制都很重要。